Pulike Bio obtains registration for new poultry vaccine

Pulike Biological Engineering Co., Ltd. (SSE:603566) announced that it has received a new veterinary drug registration certificate from the Ministry of Agriculture and Rural Affairs for its "Mycoplasma synoviae inactivated vaccine (HN01 strain)." Jointly developed with other entities, the vaccine is classified as a Class III new veterinary drug and is designed to prevent infectious synovitis in chickens. The vaccine, containing the HN01 strain, induces immunity within 30 days, providing protection for six months. As of the announcement date, the company has invested CNY 5.3124 million in the project. This successful development will enrich the company's range of poultry vaccines and is expected to create new opportunities for business growth. Only one other similar poultry vaccine (YBF-MS1 strain) has been approved in China as of this announcement.